Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	9.03	6.91	10.49	5.9	12.26
Short-Term Investments	0.02	0.02	4.02	16.02	0.02
Cash & Short-Term Investments	9.05	6.93	14.51	21.92	12.28
Cash Growth	30.63%	-52.27%	-33.78%	78.41%	-23.79%
Accounts Receivable	3.7	4.91	3.92	2.58	1.72
Receivables	3.7	4.91	3.92	2.58	1.72
Prepaid Expenses	1.27	1.06	0.31	0.25	0.24
Total Current Assets	14.02	12.9	18.74	24.74	14.25
Property, Plant & Equipment	0.22	0.01	0	0	0
Other Intangible Assets	1.65	1.65	1.65	3.37	3.37
Other Long-Term Assets	0.39	-	-	-	-
Total Assets	16.28	14.56	20.39	28.11	17.62

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Accounts Payable	1.73	3.04	1.72	1.78	0.51
Accrued Expenses	0.12	0.07	0.22	0.2	0.12
Short-Term Debt	-	-	0.33	-	-
Current Portion of Leases	0.11	-	-	-	-
Other Current Liabilities	-	0.05	0.05	0.05	0.18
Total Current Liabilities	1.96	3.16	2.32	2.03	0.81
Long-Term Leases	0.12	-	-	-	-
Pension & Post-Retirement Benefits	-	0.01	0.01	0.01	0.05
Total Liabilities	2.08	3.17	2.33	2.03	0.86

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Common Stock	102.79	93.89	93.27	93.25	77.26
Retained Earnings	-90.55	-84.07	-77.4	-69.31	-62.45
Comprehensive Income & Other	1.96	1.57	2.19	2.14	1.95
Shareholders' Equity	14.2	11.39	18.07	26.08	16.76
Total Liabilities & Equity	16.28	14.56	20.39	28.11	17.62

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Total Debt	0.22	-	0.33	-	-
Net Cash (Debt)	8.83	6.93	14.18	21.92	12.28
Net Cash Growth	27.41%	-51.16%	-35.28%	78.41%	-22.99%
Net Cash Per Share	0.01	0.01	0.02	0.03	0.02
Filing Date Shares Outstanding	1,057	805.32	805.32	805.27	654.32
Total Common Shares Outstanding	1,057	805.32	805.32	805.27	654.32
Working Capital	12.06	9.74	16.42	22.71	13.44
Book Value Per Share	0.01	0.01	0.02	0.03	0.03
Tangible Book Value	12.55	9.74	16.42	22.71	13.4
Tangible Book Value Per Share	0.01	0.01	0.02	0.03	0.02

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error